quinazolines has been researched along with 4-butyrolactone in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jelínková, L; Kubelka, M | 1 |
Handel, MA; Sun, F | 1 |
Baek, JM; Boulbes, D; Esteva, FJ; Gomez-Cabello, D; Hawke, DH; Hortobagyi, GN; Hung, MC; Jin, Q; Lee, MH; Wang, YN; Yeung, SC; Yuan, LX | 1 |
Cufí, S; Del Barco, S; Martin-Castillo, B; Menendez, JA; Oliveras-Ferraros, C; Sauri-Nadal, T; Vazquez-Martin, A | 1 |
Bessadóttir, M; Eccles, S; Gowan, S; Ogmundsdóttir, HM; Ögmundsdóttir, S; Skúladóttir, EÁ | 1 |
5 other study(ies) available for quinazolines and 4-butyrolactone
Article | Year |
---|---|
Neither Aurora B activity nor histone H3 phosphorylation is essential for chromosome condensation during meiotic maturation of porcine oocytes.
Topics: 4-Butyrolactone; Animals; Aurora Kinases; Benzamides; Chromosomes; Cycloheximide; Female; Histones; In Vitro Techniques; Meiosis; Oocytes; Phosphorylation; Protein Serine-Threonine Kinases; Quinazolines; Swine | 2006 |
Regulation of the meiotic prophase I to metaphase I transition in mouse spermatocytes.
Topics: 4-Butyrolactone; Animals; Aurora Kinases; Benzamides; Cell Cycle Proteins; Chromosomal Proteins, Non-Histone; Cohesins; Cyclin-Dependent Kinases; Enzyme Inhibitors; Histones; Male; Meiotic Prophase I; Metaphase; Mice; Okadaic Acid; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Quinazolines; Spermatocytes | 2008 |
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells.
Topics: 4-Butyrolactone; Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Fatty Acid Synthases; Female; Fluorescent Antibody Technique; Gene Expression; Humans; Lapatinib; Mass Spectrometry; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neuregulin-1; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; RNA, Small Interfering; Signal Transduction | 2010 |
Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib.
Topics: 4-Butyrolactone; Antineoplastic Agents; Breast Neoplasms; Fatty Acid Synthases; Female; Humans; Quinazolines; Receptor, ErbB-2 | 2011 |
Effects of anti-proliferative lichen metabolite, protolichesterinic acid on fatty acid synthase, cell signalling and drug response in breast cancer cells.
Topics: 4-Butyrolactone; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Fatty Acid Synthases; Female; Humans; Lapatinib; Lichens; Molecular Structure; Quinazolines; Receptor, ErbB-2; Signal Transduction | 2014 |